Hepatitis is an inflammation of the liver mainly induced by autoimmunity, chemical, or infectious agents. In the United States, the third most prevalent form of chronic infectious hepatitis is caused by hepatitis C virus (HCV). Worldwide there are an estimated 170 million people infected with HCV with nearly 4 million infected individuals in the United States.
>> Learn more
ViroBay is investigating two new promising approaches for the treatment of hepatitis C: protease inhibitors and polymerase inhibitors.
 |
 |
 |
 |
 |
 |
| Protease inhibitors | |||||
| VBY 376 |  |
||||
| Next Generation |  |
||||
| Polymerase Inhibitors | |||||
| VBY 708 | |
||||
